These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 15359292

  • 1. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC.
    Cancer Res; 1998 Dec 15; 58(24):5731-7. PubMed ID: 9865731
    [Abstract] [Full Text] [Related]

  • 7. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
    Rivas C, Miller AR, Collado M, Lam EW, Apperley JF, Melo JV.
    Mol Ther; 2001 May 15; 3(5 Pt 1):642-52. PubMed ID: 11356068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM.
    Cancer Gene Ther; 1996 May 15; 3(6):373-84. PubMed ID: 8988840
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 15; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 11. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.
    J Gene Med; 2006 Sep 15; 8(9):1105-20. PubMed ID: 16802401
    [Abstract] [Full Text] [Related]

  • 12. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
    Hanari N, Matsubara H, Hoshino I, Akutsu Y, Nishimori T, Murakami K, Sakata H, Miyazawa Y, Ochiai T.
    Anticancer Res; 2007 Sep 15; 27(4B):2305-10. PubMed ID: 17695518
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer.
    Hayashi S, Emi N, Yokoyama I, Namii Y, Uchida K, Takagi H.
    Cancer Gene Ther; 1997 Sep 15; 4(6):339-44. PubMed ID: 9408603
    [Abstract] [Full Text] [Related]

  • 14. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Sep 15; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 15. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 15; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 16. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H, Tachibana I, Tanio Y, Kishimoto T.
    Cancer Res; 1999 Oct 01; 59(19):4906-11. PubMed ID: 10519403
    [Abstract] [Full Text] [Related]

  • 17. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T.
    Cancer Gene Ther; 1997 Oct 01; 4(2):91-6. PubMed ID: 9080117
    [Abstract] [Full Text] [Related]

  • 18. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug 01; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 19. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 01; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 20. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
    Kagaya T, Nakamoto Y, Sakai Y, Tsuchiyama T, Yagita H, Mukaida N, Kaneko S.
    Cancer Gene Ther; 2006 Apr 01; 13(4):357-66. PubMed ID: 16224495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.